B cell activation in patients with rheumatic disease: association with an increased ratio of T_h2: T_h1 cytokine secreting cells

REFERENCES

• Mosmann TR, Coffman RL: Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 147–171, 1989.
   Google Scholar
• Mosmann TR, Cherwinski H, Bond MW et al. : Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357, 1986.
   PubMed Web of Science ®Google Scholar
• Moore KW, Vieira P, Fiorentino DR et al: Homology of cytokine synthesis inhibitory factor (IL-10) to the EBV gene BCRF1. Science 248: 1230–1234, 1990.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Hu-Li J, Seder RA et al: IL-4 suppresses IL-2 and IFN-y production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci USA 90: 5914–5918, 1993.
   Google Scholar
• Seder RA, Paul WE, Mark MD et al: The presence of IL-4 during in vitro proming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 176: 1091–1098, 1992.
   PubMed Web of Science ®Google Scholar
• Parronchi P, DeCarli M, Manetti R et al: IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Thl or Th2 human T cell clones. J Immunol 149: 2977–2983, 1992.
   PubMed Web of Science ®Google Scholar
• Shirai A, Conover J, Klinman DM: Increased activation and altered ratio of IFNg: IL-4 secreting cells in MRL/lpr mice. Autoimmunity 21: 107–116, 1996.
   Google Scholar
• Takahashi S, Fossati L, Owamoto M et al: Imbalance towards Thl predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97: 1597–1604, 1996.
   PubMed Web of Science ®Google Scholar
• Steinberg AD, Klinman DM: Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin N Am 14: 25–41, 1988.
   PubMedGoogle Scholar
• Klinman DM, Steinberg AD: Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165: 1755–1760, 1987.
   PubMed Web of Science ®Google Scholar
• Klinman DM, Eisenberg RA, Steinberg AD: Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice. J Immunol 1440: 506–512, 1990.
   Google Scholar
• Linker-Israeli M, Deans R, Wallace D et al: Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 147: 117–123, 1991.
   PubMed Web of Science ®Google Scholar
• Kitani A, Hara M, Hirose T et al: Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and EL-6R expression. Clin Exp Immunol 88: 75–83, 1992.
   PubMed Web of Science ®Google Scholar
• Nagafuchi H, Suzuki N, Mizushima Y et al: Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J Immunol 151: 6525–6534, 1993.
   PubMed Web of Science ®Google Scholar
• Kitani A, Hara M, Hirose T et al: Heterogeneity of B cell responsiveness to interleukin 4, inter-leukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus. Clin Exp Immunol 77: 31–36, 1989.
   PubMedGoogle Scholar
• Spronk P, Ter Borg E, Limburg P et al: Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity? Clin Exp Immunol 90: 106–110 1992.
   PubMed Web of Science ®Google Scholar
• Al-Janadi M, Al-Balla S, Al-Dalaan A et al: Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J Clin Immunol 13: 58–67, 1993.
   PubMed Web of Science ®Google Scholar
• Hagiwara E, Gourley M, Lee S et al: Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of IL-10: IFNgammasecreting cells in the peripheral blood. Arthritis Rheum 39: 379–385, 1996.
   PubMed Web of Science ®Google Scholar
• Briere F, Servet-Delprat C, Bridón J et al: Human interleukin-10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgGl and IgG3. J Exp Med 179: 757–762, 1994.
   PubMed Web of Science ®Google Scholar
• Llórente L, Zou W, Levy Y et al.: Role of IL-10 in the B lymphocyte hyperactivity and autoantibody production of human SLE. J Exp Med 181: 839–844, 1995.
   PubMed Web of Science ®Google Scholar
• Llórente L, Richaud-Patin Y, Wijdenes J et al.: Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4: 421–430, 1993.
   PubMed Web of Science ®Google Scholar
• Houssiau FA, Lefebvre C, Vanden Berghe M et al: Serum IL-10 titers in SLE reflect disease activity. Lupus 4: 393–395, 1995.
   PubMed Web of Science ®Google Scholar
• Richaud-Patin R, Alcocer-Varela J, Llórente L: High levels of Ti,2 cytokine gene expression in SLE. Rev Invest Clin 47: Ibi-111, 1995.
   Google Scholar
• Kroemer G, Martinez-a C: Short Analytical review: cytokines and autoimmune disease. Clin Immunol Immunopathol 61: 275–295, 1991.
   PubMedGoogle Scholar
• Goldman M: Review: cytokines in the pathogenesis of systemic lupus erythematosus. Autoimmunity 8: 173–179, 1990.
   Google Scholar
• Horwitz DA, Wang H, Gray JD: Cytokine gene profiles in circulating blood mononuclear cells from patients with SLE: Increased IL-2 but not IL-4 mRNA. Lupus 3: 423–428, 1994.
   PubMed Web of Science ®Google Scholar
• Huang YP, Perrin LH, Miescher PA et al.: Correlation of T and B cell activities in vitro and serum JL-2 levels in systemic lupus erythematosus. J Immunol 141: 827–833, 1988.
   PubMed Web of Science ®Google Scholar
• Hagiwara E, Abbasi F, Mor G et ai: Phenotype and frequency of cells secreting IL-2, IL-4, IL-6 IL-10, JFNg and TNFa in human peripheral blood. Cytokine 7: 815–822, 1995.
   PubMed Web of Science ®Google Scholar
• Hagiwara E, Adams EM, Plotz PH et al.: Abnormal cytokine production by peripheral blood mononuclear cells from patients with polymyositis and dermatomyositis. Clin Exp Rheum 14: 485–491, 1996.
   Google Scholar
• Feldman M, Brennan FM, Chantry D et al: Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 119: 105–123, 1991.
   Google Scholar
• Firestein GS, Alvaro-Gracia J, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis./Immunol 144: 3347, 1990.
   Google Scholar
• Miyasaka N, Sato K, Goto M: Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction. Arthritis Rheum 31: 480, 1988.
   PubMed Web of Science ®Google Scholar
• Fong K, Boey M, Koh W et al: Cytokine concentration in the synovial fluid and plasma of rheumatoid arthritis patients: correlation with bony erosions. Clin Exp Rheum 12: 55–58, 1994.
   PubMed Web of Science ®Google Scholar
• Hirano T, Matsuda T, Turner M et al: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797–1801, 1988.
   PubMed Web of Science ®Google Scholar
• Schulze-Koops H, Lipsky PE, Kavanaugh AF et al: Elevated Thl or ThO-like cytokine mRNA in periphal circulation of patients with rheumatoid arthritis. J Immunol 155: 5029–5037, 1995.
   PubMed Web of Science ®Google Scholar
• Quayle AJ, Chomarat P, Miossex P et al: Rheumatoid inflammatory T cell clones express mostly Thl but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 38: 75–82, 1993.
   Google Scholar
• Wolf RE, Baethge BA: JL-1, IL-2 and soluble IL-2R in polymyositis. Arthritis Rheum 33:1007–1014, 1990.
   PubMedGoogle Scholar
• Mantegazza R, Bernasconi P: Cellular aspects of myositis. Curr Opin Rheum 6: 568–574, 1994.
   PubMedGoogle Scholar
• Villarreal GM, Alcocer-Varela J, Llórente L: Cytokine gene and CD25 antigen expression in peripheral blood T cells from patients with primary Sjogren’s syndrome. Autoimmunity 20: 223–229, 1995.
   Web of Science ®Google Scholar